Saruta T, Eguchi T, Nakamura R, Misumi J, Kondo K, Oka M
Jpn Heart J. 1980 Jan;21(1):103-9. doi: 10.1536/ihj.21.103.
In order to reveal the mechanism of renin inhibition by beta adrenergic blocking agents, the effects of dl-, d-, l-propranolol and pindolol on renin release were studied. This was done by injecting them intraperitoneally or by using an in vitro system of rat kidney slices. In the in vivo study, dl-, d-, and l-propranolol inhibited plasma renin activity and renal renin content significantly in normal rats. Furthermore, in the in vitro study, the basal levels of renin in the media and that in the kidney were significantly inhibited by these agents. Pindolol also inhibited renin release, but its effects were significantly less than those of other agents. The finding that d-propranolol which has little beta adrenergic blocking action inhibited renin release, and that the effects of pindolol which displays strong beta adrenergic blocking action but little membrane stabilizing action, were less than those of other agents, may suggest that the inhibitory effects of beta adrenergic blocking agents on renin release are dependent mainly on the membrane stabilizing action rather than the beta adrenergic blocking action.
为了揭示β肾上腺素能阻滞剂抑制肾素的机制,研究了消旋、右旋、左旋普萘洛尔及吲哚洛尔对肾素释放的影响。通过腹腔注射或使用大鼠肾切片体外系统进行研究。在体内研究中,消旋、右旋和左旋普萘洛尔显著抑制正常大鼠的血浆肾素活性和肾脏肾素含量。此外,在体外研究中,这些药物显著抑制培养基和肾脏中肾素的基础水平。吲哚洛尔也抑制肾素释放,但其作用明显小于其他药物。几乎没有β肾上腺素能阻断作用的右旋普萘洛尔抑制肾素释放,而具有强β肾上腺素能阻断作用但几乎没有膜稳定作用的吲哚洛尔的作用小于其他药物,这一发现可能表明β肾上腺素能阻滞剂对肾素释放的抑制作用主要取决于膜稳定作用而非β肾上腺素能阻断作用。